Article Versions Notes

Incorvaia L, Fanale D, Badalamenti G, Brando C, Bono M, De Luca I, Algeri L, Bonasera A, Corsini LR, Scurria S, et al. A “Lymphocyte MicroRNA Signature” as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming. Cancers. 2020; 12(11):3396. https://doi.org/10.3390/cancers12113396

Incorvaia, Lorena, Daniele Fanale, Giuseppe Badalamenti, Chiara Brando, Marco Bono, Ida De Luca, Laura Algeri, Annalisa Bonasera, Lidia Rita Corsini, Salvatore Scurria, and et al. 2020. "A “Lymphocyte MicroRNA Signature” as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming" Cancers 12, no. 11: 3396. https://doi.org/10.3390/cancers12113396

Incorvaia, L., Fanale, D., Badalamenti, G., Brando, C., Bono, M., De Luca, I., Algeri, L., Bonasera, A., Corsini, L. R., Scurria, S., Iovanna, J. L., Russo, A., & Bazan, V. (2020). A “Lymphocyte MicroRNA Signature” as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming. Cancers, 12(11), 3396. https://doi.org/10.3390/cancers12113396